FGF19 and Insulin resistance: Furthermore, the inhibition of AMPK, SIRT‐1 and PGC‐1α reversed the beneficial effects of FGF19 on mitigating PA‐ and HFD‐induced lipid droplet accumulation and insulin resistance.